Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001596584-15-000001
Filing Date
2015-05-01
Accepted
2015-05-01 13:29:54
Documents
1
Effectiveness Date
2015-05-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8892
  Complete submission text file 0001596584-15-000001.txt   9926
Mailing Address 515 CONGRESS AVENUE, SUITE 1800 AUSTIN TX 78701
Business Address 515 CONGRESS AVENUE, SUITE 1800 AUSTIN TX 78701 15124220155
Lumos Pharma, Inc. (Filer) CIK: 0001596584 (see all company filings)

EIN.: 383830503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-211391 | Film No.: 15823336